Immunotherapy will become a hot mobile medical treatment has been set to remain only competition
Last year, the medical industry experienced a wave of investment fever and entrepreneurial fever. After the outbreak of Wei Zexi this year, the medical sector seems to have cooled down. Coupled with the impact of the cold winter, the medical industry with high thresholds and high risks has discouraged many investors. For Xianyu Capital, which mainly deals with biomedicine and medical equipment , health and people's livelihood security, and life resources technology, how do they find investment opportunities in this “cold wave� What other segments of the industry will re-energize? A few days ago, Liu Mulong, founding partner of Xianyu Capital, said that in his view, the field of immunotherapy in precision treatment will continue to be hot, and the overall situation of mobile medicine has been set, and will face shuffling. Regarding how to choose an investment company, Liu Mulong believes that he chooses the company basically from two perspectives. The first is that from the perspective of technological advancement, we must first put it on the global perspective to see if it has the potential for international competition. In his view, Xianyu Capital has invested in two sectors of biomedicine and bioengineering. Many projects have the potential for international operations, and the more sophisticated things, the more high-end markets are needed. "China's market, although it has a large level of improvement over the past decade or two, can also consume some cutting-edge, high-end things, which reflects the high-end demand in the market, but the domestic market is not very large. Without combining with the high-end market, there is no possibility of growth." In the medical sector, Liu Mulong used another perspective: the international advanced and the matching of the domestic market, with market matching as the main factor. He analyzed that the domestic market is very rich in the medical and pharmaceutical fields, both very high-end needs and very backward areas that only need basic needs. At this time, they will grasp the appropriate investment time and project development rhythm of a medical product . "When you enter the market, you must lead the market, but you can't leave the market. This requires a deep understanding of the industry and is a reflection of the comprehensive level." Since the Wei Zexi incident, the field of immune cell therapy has cooled down compared with before, but Liu Mulong is still optimistic about this field. He pointed out that Xianyu Capital currently has some forward-looking layouts in the field of immunotherapy, and the cell therapy in the Wei Zexi incident was not the same as immunotherapy. "Cell treatment also has the scientific basis of immunity, but it is not the same in nature. Immunotherapy may be very promising in the field of follow-up anti-tumor treatment. We made forward-looking judgments and layouts. Now the company may still be developing, but the market It has already demonstrated its recognition of this field, and it is likely to become a hot spot in the field of precision treatment, which represents the cutting-edge technology level." When talking about the mobile medical sector in the medical segment, Liu Mulong insisted on his earliest point of view: relatively cold-eyed and not actively involved. He believes that Internet medical and mobile medical care are different from the general Internet business model. The medical and pharmaceutical investment industry itself has special characteristics. It is not a purely free competitive market, but a necessary and strong government. Intervention, business logic is completely different from other industries. Eye Massage,Best Eye Massager,Eye Care Massager,Eye Roller Massager Shenzhen Jie Zhong Lian Investment Co., Ltd. , https://www.szmeizonscares.com